GlaxoSmithKline, the United Kingdom’s biggest drugmaker, was ordered to recall an antibiotic on sale in China following similar moves in Taiwan and Hong Kong, after authorities detected an industrial plasticiser in the drug.
China has halted sales of Augmentin, manufactured by Glaxo after finding Diisodecyl phthalate, known as DIDP, the State Food and Drug Administration said yesterday in a statement. The medicine is used to treat bacterial infections.
Earlier this month, Taiwan and Hong Kong also ordered a recall of Augmentin. Animal tests suggest long-term consumption of the chemical might affect the liver, according to a statement from Hong Kong’s Department of Health.